Ariglide-M

Ariglide-M by Arion Healthcare is an advanced, clinically validated dual-action oral anti-diabetic medication engineered for the comprehensive management and balanced control of Type 2 Diabetes Mellitus. Formulated in strict adherence to premium quality standards, each uncoated tablet pairs two potent therapeutic agents: an insulin secretagogue (Gliclazide) and a biguanide insulin sensitizer (Metformin Hydrochloride). Together, they deliver a multi-pathway mechanism of action that significantly optimizes blood glucose homeostasis throughout the day.

By addressing both insulin deficiency and peripheral insulin resistance simultaneously, Ariglide-M assists patients in avoiding dangerous glycemic spikes and drops. Beyond metabolic control, this strategic combination helps minimize long-term diabetic complications, supporting overall systemic well-being, sustained daily physical energy, and an improved quality of life under appropriate clinical supervision.

Key Benefits 

• Dual Action Formula: Combines Gliclazide and Metformin seamlessly to drive optimal, multi-pathway glycemic management.

• Effective Blood Sugar Control: Successfully reduces baseline HbA1c profiles and minimizes postprandial glucose spikes.

• Supports Overall Health: Boosts daily physiological energy levels while reducing risk profiles for long-term diabetes complications.

Indications

• Management of Type 2 Diabetes Mellitus (NIDDM) in adults when dietary modifications, regular physical exercise, and single-agent monotherapy fail to provide adequate glycemic control.

• Patients requiring multi-channel glycemic regulation to improve insulin sensitivity while stimulating targeted pancreatic insulin secretion.

Side Effects

• Hypoglycemia (Low Blood Sugar): Occurs primarily if meals are skipped, characterized by dizziness, sweating, and tremors.

• Gastrointestinal Disturbances: Temporary nausea, vomiting, diarrhea, abdominal discomfort, or a metallic taste in the mouth.

• Dermatological Reactions: Rare skin rashes, pruritus, or redness.

• Lactic Acidosis: A rare but serious metabolic complication linked to Metformin accumulation, requiring immediate medical intervention.

Frequently Asked Questions 

Q1: What is Ariglide-M and how does it function in the body?

Ariglide-M is a dual-action anti-diabetic tablet combining Gliclazide (80mg) and Metformin Hcl (500mg). It lowers blood sugar by simultaneously stimulating insulin release from the pancreas and increasing peripheral tissue sensitivity to insulin.

Q2: How and when should Ariglide-M tablets be taken for best results?

It must be taken exactly as prescribed by your physician, usually with or immediately after major meals. Taking the medication alongside food significantly reduces the possibility of experiencing initial stomach upsets or gastrointestinal discomfort.

Q3: Can I consume alcohol while taking Ariglide-M therapy?

No, it is highly advised to avoid alcohol intake while using this prescription. Alcohol drastically increases the underlying risks of severe hypoglycemia and can trigger a critical, adverse metabolic condition known as lactic acidosis.

Q4: What immediate steps should I take if I experience symptoms of low blood sugar?

If you feel dizzy, shaky, or sweaty, consume a fast-acting sugar source like fruit juice, candy, or glucose powder immediately. Follow it up with a proper meal and report the event to your treating doctor to review your dosage.

Q5: Is Ariglide-M completely safe for usage during pregnancy or breastfeeding?

Ariglide-M is not recommended for pregnant or lactating women, as blood sugar shifts during these stages require alternative therapies. Always inform your doctor if you are planning a pregnancy to transition to safer treatments like insulin.